Santen Pharmaceutical Co., Ltd. (TYO: 4536)

Santen Pharmaceutical Revenue

Santen Pharmaceutical had revenue of 71.63B JPY in the quarter ending September 30, 2024, a decrease of -2.43%. This brings the company's revenue in the last twelve months to 302.56B, up 2.24% year-over-year. In the fiscal year ending March 31, 2024, Santen Pharmaceutical had annual revenue of 301.97B with 8.22% growth.

• Revenue (ttm): 302.56B
• Revenue Growth: +2.24%
• P/S Ratio: 1.82
• Revenue / Employee: 80.81M
• Employees: 3,744
• Market Cap: 529.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	301.97B	22.93B	8.22%
Mar 31, 2023	279.04B	12.78B	4.80%
Mar 31, 2022	266.26B	16.65B	6.67%
Mar 31, 2021	249.61B	8.05B	3.33%
Mar 31, 2020	241.56B	7.53B	3.22%